ArticleTransboundary and emerging diseases2022

Safety study of Rift Valley Fever human vaccine candidate (DDVax) in mosquitoes.

Corey L Campbell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.